Immunization News and Research

RSS

Adaptive immune responses in adults of various ages receiving 2 doses of the BNT162b2 mRNA vaccine

Researchers assessed the correlation between immunosenescence and poor COVID-19 vaccination outcomes in older adults.

21 Oct 2022

Analgesic use after COVID-19 vaccination does not negatively affect antibody responses

In a recent study posted to the medRxiv* preprint server, University of Arizona researchers assessed the relationship between antibody responses and analgesic usage after coronavirus disease 2019 (COVID-19) vaccination.

20 Oct 2022

Breakthrough infection risk and immune responses to vaccines associated with human leukocyte antigen alleles

Researchers from the U.K. used data from clinical trials of the Oxford-AstraZeneca COVID-19 vaccine ChAdOx1 nCoV-19 to understand the genetic factors contributing to the individual variations in the antibody responses to the vaccine.

20 Oct 2022

Impaired SARS-CoV-2 neutralization after booster vaccination in the elderly

A recent study investigates poorer vaccine responses observed in the elderly following receipt of a COVID-19 booster vaccination dose.

19 Oct 2022

The prevalence of pneumococcal carriage in Serbia during COVID

Scientists explore the prevalence of Streptococcus pneumoniae carriage during the COVID-19 pandemic in older adults.

17 Oct 2022

Study highlights the importance of getting vaccinated for flu

An international team of researchers has demonstrated that among patients hospitalized for influenza, those who were vaccinated had less severe infections, including reducing the odds for children requiring admittance to an intensive care unit by almost half.

12 Oct 2022

Timely COVID-19 boosters may prevent care facility outbreaks

A new study examines vaccine efficacy during an outbreak of the SARS-CoV-2 Delta variant in a long-term care facility.

11 Oct 2022

Factors associated with COVID‐19 vaccination hesitancy among French healthcare workers

A recent study describes the results from interviews of healthcare workers to determine factors associated with their vaccine hesitancy.

10 Oct 2022

Chronic liver disease in COVID-19 patients

A recent study summarizes the clinical outcomes of COVID-19 patients with chronic liver disease.

10 Oct 2022

Effect of COVID-19 mRNA vaccination on COVID-19 severity during Omicron BA.4 and BA.5 predominance periods

In a new study, researchers estimated the association of first-generation messenger ribonucleic acid (mRNA) vaccines (BNT162b2, mRNA-1273) with coronavirus disease 2019 (COVID-19)-related medical encounters.

10 Oct 2022

Study evaluates efficacy of a candidate SARS-CoV-2 subunit vaccine to protect endangered black-footed-ferrets

In a new study, researchers assessed the safety, efficacy, and immunogenicity of a candidate SARS-CoV-2 subunit vaccine in black-footed ferrets (BFF), and investigated the susceptibility of these endangered North American mammals to the virus.

7 Oct 2022

HRSA award recognizes Family Health Centers at NYU Langone for maternal and child care improvement

The Family Health Centers at NYU Langone has earned national recognition from the Health Resources and Services Administration for quality improvement achievements in maternal and child healthcare.

6 Oct 2022

Intranasal vaccine represents an effective broad-spectrum COVID-19 vaccine strategy

Researchers evaluated the efficacy of dNS1-RBD, a novel intranasal COVID-19 vaccine.

6 Oct 2022

Global burden of liver cancer could rise by more than 55% by 2040, analysis reveals

A new analysis reveals that primary liver cancer was among the top three causes of cancer death in 46 countries in 2020 and the number of people diagnosed with or dying from primary liver cancer per year could rise by more than 55% by 2040.

5 Oct 2022

Vaccine hesitancy not the main barrier to immunization in low-income countries

Low vaccination rates in poorer countries have little to do with so-called “vaccine hesitancy” according to a study that examined access to COVID-19 tools across 14 low-income countries.

5 Oct 2022

Study finds the majority of post-vaccination monkeypox infections occur within 2 weeks of receiving the first dose of MVA-BN

Researchers described the human monkeypox virus infection after vaccination with the modified Vaccinia Ankara-Bavarian Nordic (MVA-BN) vaccine.

5 Oct 2022

Omicron reduces host antibody response by lower B-cell antigenicity

A new study explores the functional relevance of some Omicron mutations in terms of their ability to escape neutralizing antibody responses.

4 Oct 2022

Spike-specific memory B cells develop resilience to SARS-CoV-2

In a recent study posted to the bioRxiv* preprint server, researchers explored the cross-reactivity, avidity, and kinetics of memory B-cells and serum antibodies in vaccinated and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infected individuals.

4 Oct 2022

COVID-19 vaccination offers sustained and potent neutralizing protection against variants compared to natural infection

In a new study, researchers assessed the immunoglobulin (Ig)-G responses to SARS-CoV-2 after natural infection or vaccination.

3 Oct 2022

COVID-19 cases, hospitalizations, and fatalities prevented by SARS-CoV-2 vaccination within the first 6 months after the vaccine became available

Researchers assessed the effect of SARS-CoV-2 vaccination in the US.

28 Sep 2022

Immunization News and Research

Adaptive immune responses in adults of various ages receiving 2 doses of the BNT162b2 mRNA vaccine

Analgesic use after COVID-19 vaccination does not negatively affect antibody responses

Breakthrough infection risk and immune responses to vaccines associated with human leukocyte antigen alleles

Impaired SARS-CoV-2 neutralization after booster vaccination in the elderly

The prevalence of pneumococcal carriage in Serbia during COVID

Study highlights the importance of getting vaccinated for flu

Timely COVID-19 boosters may prevent care facility outbreaks

Factors associated with COVID‐19 vaccination hesitancy among French healthcare workers

Chronic liver disease in COVID-19 patients

Effect of COVID-19 mRNA vaccination on COVID-19 severity during Omicron BA.4 and BA.5 predominance periods

Study evaluates efficacy of a candidate SARS-CoV-2 subunit vaccine to protect endangered black-footed-ferrets

HRSA award recognizes Family Health Centers at NYU Langone for maternal and child care improvement

Intranasal vaccine represents an effective broad-spectrum COVID-19 vaccine strategy

Global burden of liver cancer could rise by more than 55% by 2040, analysis reveals

Vaccine hesitancy not the main barrier to immunization in low-income countries

Study finds the majority of post-vaccination monkeypox infections occur within 2 weeks of receiving the first dose of MVA-BN

Omicron reduces host antibody response by lower B-cell antigenicity

Spike-specific memory B cells develop resilience to SARS-CoV-2

COVID-19 vaccination offers sustained and potent neutralizing protection against variants compared to natural infection

COVID-19 cases, hospitalizations, and fatalities prevented by SARS-CoV-2 vaccination within the first 6 months after the vaccine became available

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News